View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Ruxolitinib 20, T-Cell Lymphoma / T-Cell Prolymphocyte Leukemia
Protocol-ID: 2478 V1.0 (Mini), RUXO20, T-NHL/T-PLLIndication(s)
- NHL, T-Cell Type, Angioimmunoblastic; ICD-10 C86.5
JAK2 rearrangement - NHL, T-Cell Type, Cutaneous, Unspecified; ICD-10 C84.8
JAK2 rearrangement - NHL, T-Cell Type, Peripheral, Unspecified; ICD-10 C84.4
JAK2 rearrangement - T-Cell Prolymphocyte Leukemia; ICD-10 C91.6-
JAK2 rearrangement
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 11.10.2023